Disclosure Of Interests In Other Entities [Text Block]

Ascelia Pharma - Filing #689421

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31
Disclosure of interests in other entities [text block]	—	—	—		—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]	—	—	—		—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Profit (loss), attributable to non-controlling interests	—	—	—	– SEK	—	—	—	—	—	—	—	—	—	—	– SEK	—	—
Current assets	160 869 SEK	—	—	—	—	—	—	—	—	274 611 SEK	—	—	—	—	—	—	—
Non-current assets	57 700 SEK	—	—	—	—	—	—	—	—	58 882 SEK	—	—	—	—	—	—	—
Current liabilities	37 518 SEK	—	—	—	—	—	—	—	—	25 106 SEK	—	—	—	—	—	—	—
Non-current liabilities	193,000 SEK	—	—	—	—	—	—	—	—	553,000 SEK	—	—	—	—	—	—	—
Revenue	—	—	—	– SEK	—	—	—	—	—	—	—	—	—	—	– SEK	—	—
Profit (loss)	—	– SEK	131 223 SEK	131 223 SEK	131 223 SEK	– SEK	– SEK	– SEK	– SEK	—	– SEK	– SEK	125 903 SEK	– SEK	125 903 SEK	125 903 SEK	—
Comprehensive income	—	– SEK	130 504 SEK	130 504 SEK	131 223 SEK	– SEK	718,000 SEK	– SEK	– SEK	—	– SEK	135,000 SEK	125 768 SEK	– SEK	125 768 SEK	125 903 SEK	—
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income	—	—	—	718,000 SEK	—	—	—	—	—	—	—	—	—	—	135,000 SEK	—	—
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	149 555 SEK	—	—	—	—	—	—	—	—	261 599 SEK	—	—	—	—	—	—	184 686 SEK
Tax expense (income)	—	—	—	1 933 SEK	—	—	—	—	—	—	—	—	—	—	3 620 SEK	—	—